OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
Decoding the neurobiological underpinnings of psychiatric disorders such as addiction is critically linked to expanding insights obtained from the human brain which can inform targeted treatments. The important need for the development of novel non-addictive medications is particularly critical today to address the persistent opioid and overdose epidemic crisis facing society worldwide. The presentation will provide molecular insights gained from post-mortem studies of human heroin users and complementary mechanistic animal studies that identify specific epigenetic, neurodegenerative and synaptic plasticity biological processes that offer druggable targets for opioid use disorder.
SPEAKER BIOGRAPHY
Dr. Yasmin Hurd is Professor of Psychiatry, Neuroscience and Pharmacological Sciences as well as the Director for the Addiction Institute at the Icahn School of Medicine at Mount Sinai in New York. She is an internationally renowned neuroscientist whose translational research examines the neurobiology of substance use disorders and related psychiatric disorders with primary focus on opioid abuse and the developmental effects of cannabis. She is a member of both the National Academy of Sciences and the National Academy of Medicine.
